Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors.

  title={Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors.},
  author={S. Abdelsayed and N. T. Ha Duong and J. Hai and M. H{\'e}madi and J. El Hage Chahine and P. Verbeke and N. Serradji},
  journal={Bioorganic \& medicinal chemistry letters},
  volume={24 16},
Chlamydia trachomatis (Ct) is a bacterial human pathogen responsible for the development of trachoma, the worldwide infection leading to blindness, and is also a major cause of sexually transmitted diseases. As iron is an essential metabolite for this bacterium, iron depletion presents a promising strategy to limit Ct proliferation. The aim of this study is to synthesize 3-isoxazolidone derivatives bearing known chelating moieties in an attempt to develop new bactericidal anti-Chlamydiaceae… Expand
In vitro activities of a new fluoroquinolone derivative highly active against Chlamydia trachomatis.
Its anti-Chlamydia activity is higher than that of ciprofloxacin and seems to be related to the fluoroquinolone moiety of the molecule, which is also responsible for the complexation of iron(III), as demonstrated by spectrophotometric titration. Expand
Piperazine derivatives as iron chelators: a potential application in neurobiology
Polysubstituted piperazine derivatives were synthesized and fully characterized by nuclear magnetic resonance and mass spectroscopy demonstrating that high affinity for iron is not associated with important neuroprotective effects. Expand
Circulation des Chlamydiaceae en filières avicoles, exposition des professionnels et étude de la survie de Chlamydia psittaci
La chlamydiose aviaire, causee par la bacterie Chlamydia psittaci, represente un risque zoonotique important. L’infection chez l’animal est principalement asymptomatique, mais chez l’Homme elle peutExpand
Electronic spectroscopic characterization of the formation of iron(III) metal complexes: The 8-HydroxyQuinoline as ligand case study.
It is shown that the ester functionalization of HQ in 2-position weakens the formation of the iron(III) complex while its substitution in 7-position allows a salicylate coordination of the metal very close to the ideal octahedral environment. Expand


Reversal of the Antichlamydial Activity of Putative Type III Secretion Inhibitors by Iron
The potent antichlamydial activity of INPs is directly or indirectly linked with iron, and this inhibition of Chlamydia has an effect on the T3S system of this intracellular pathogen. Expand
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.
Select INPs are promising vaginal microbicide candidates as they inhibit the growth of two common sexually transmitted organisms in vitro, are active in a mouse model against C. trachomatis, are not cytotoxic and do not inhibit organisms that compose the normal vaginal flora. Expand
Influence of iron restriction on Chlamydia pneumoniae and C. trachomatis.
The effect of iron restriction on Chlamydia pneumoniae and C. trachomatis was studied by use of the iron-chelating compound deferoxamine, and the specificity exhibited by bacteria for host-iron chelates may be correlated with host and tissue tropism. Expand
Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion
A library of 58 salicylidene acylhydrazides was screened to identify inhibitors of Chlamydia growth and one compound, ME0192, had poor pharmacokinetic properties but the highest anti-chlamydial activity in vitro and therefore was tested for topical treatment in a mouse vaginal infection model. Expand
Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins
The enhanced production of this antigen by chlamydiae as a result of iron limitation is of particular importance since there is a well-documented association between chlamydial hsp60 and destructive immunopathological sequelae in infected patients. Expand
A new metabolic cell wall labeling method reveals peptidoglycan in Chlamydia trachomatis
This work used a novel approach to metabolically label chlamydial PG using d-amino acid dipeptide probes and click chemistry and found that the results of differential probe incorporation experiments conducted in the presence of ampicillin are consistent with the existence of chlamYDial PG-modifying enzymes. Expand
Chlamydia trachomatis persistence: an update.
In persistence, Chlamydia trachomatis remains viable but atypical, with an enlarged, aberrant form and quiescent metabolism, which favours chronic chlamydiosis, leading to serious sequelae. Expand
Penicillin Kills Chlamydia following the Fusion of Bacteria with Lysosomes and Prevents Genital Inflammatory Lesions in C. muridarum-Infected Mice
It is demonstrated that pG treatment of cultured cells infected with Chlamydia results in the degradation of the bacteria, and pG is significantly more efficient than doxycycline at preventing genital inflammatory lesions in C. muridarum-C57Bl/6 infected mice. Expand
Genomic Autobiographies of Chlamydiae
The genome sequences of Chlamydia trachomatis and C. pneumoniae contain the respective autobiographies that have been translated, read, and begun to be interpreted, and it appears that chlamydiae use fewer transport systems than free-living bacteria and rely on transport systems with broad specificity. Expand
Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
An increasing number of studies indicate that innate immune responses arising from the epithelium and other innate immune cells, along with changes in matrix metalloproteinase activity, are important in the development of tissue damage and scarring. Expand